pl
en
Country
pl
Language
en

New treatment perspectives for CLL patients with del17p.

Speciality: Hematology, Oncology
Language : Polski
Broadcast type : Live conference
Duration : 00:13:30
Date: December 20, 2017

New Drug Program - Ibrutinib in the treatment of patients with chronic lymphocytic leukemia allows to change the perspective on high-risk CLL therapy.

Other in: Hematology

Other in: Oncology